Related references
Note: Only part of the references are listed.The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer
Ping Yang et al.
CURRENT MEDICINAL CHEMISTRY (2020)
The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy
Francesca Castellani et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM
Stefania Scala et al.
VACCINES (2020)
CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
Amos Fumagalli et al.
MOLECULAR PHARMACOLOGY (2019)
C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges
Hui Du et al.
ACTA HAEMATOLOGICA (2019)
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
Michael Steurer et al.
HAEMATOLOGICA (2019)
CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstrom macroglobulinaemia treated with ibrutinib
Jorge J. Castillo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure
Lauren E. Heusinkveld et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2019)
Molecular Mechanism of HIV-1 Entry
Bing Chen
TRENDS IN MICROBIOLOGY (2019)
CXCR4 mutations affect presentation and outcomes in patients with Waldenstrom macroglobulinemia: A systematic review
Jorge J. Castillo et al.
EXPERT REVIEW OF HEMATOLOGY (2019)
Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X
Emily Levy et al.
FRONTIERS IN IMMUNOLOGY (2019)
WHIM syndrome: Immunopathogenesis, treatment and cure strategies
David H. McDermott et al.
IMMUNOLOGICAL REVIEWS (2019)
CXCR4S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenstrom macroglobulinemia
Joshua N. Gustine et al.
BLOOD ADVANCES (2019)
Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology
Lun Kelvin Tsou et al.
MEDICINAL RESEARCH REVIEWS (2018)
The good and bad faces of the CXCR4 chemokine receptor
Joaquin Teixido et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Separating Actin-Dependent Chemokine Receptor Nanoclustering from Dimerization Indicates a Role for Clustering in CXCR4 Signaling and Function
Laura Martinez-Munoz et al.
MOLECULAR CELL (2018)
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma
Kilannin Krysiak et al.
BLOOD (2017)
Genomics, Signaling, and Treatment of Waldenstrom Macroglobulinemia
Zachary R. Hunter et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
G Protein-Coupled Receptor Kinase 3 and Protein Kinase C Phosphorylate the Distal C-Terminal Tail of the Chemokine Receptor CXCR4 and Mediate Recruitment of β-Arrestin
Jiansong Luo et al.
MOLECULAR PHARMACOLOGY (2017)
Waldenstrom macroglobulinemia cells devoid of BTKC481S or CXCR4WHIM-like mutations acquire resistance to ibrutinib through upregulation of Bcl-2 and AKT resulting in vulnerability towards venetoclax or MK2206 treatment
A. Paulus et al.
BLOOD CANCER JOURNAL (2017)
Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition
Ellen L. Weisberg et al.
ONCOTARGET (2017)
Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements
Jordi Doijen et al.
PLOS ONE (2017)
mDia2 and CXCL12/CXCR4 chemokine signaling intersect to drive tumor cell amoeboid morphological transitions
Meghan M. Wyse et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Genomic Landscape of CXCR4 Mutations in Waldenstrom Macroglobulinemia
Stephanie Poulain et al.
CLINICAL CANCER RESEARCH (2016)
The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity
John H. Kehrl
BIOCHEMICAL PHARMACOLOGY (2016)
AMD3100 and G-CSF disrupt the cross-talk between leukemia cells and the endosteal niche and enhance their sensitivity to chemotherapeutic drugs in biomimetic polystyrene scaffolds
Zhao-Hua Shen et al.
BLOOD CELLS MOLECULES AND DISEASES (2016)
Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders
Mark Y. Chiang et al.
CURRENT OPINION IN HEMATOLOGY (2016)
CXCR4 signaling in health and disease
Tommaso Pozzobon et al.
IMMUNOLOGY LETTERS (2016)
IDENTIFICATION OF NEW BLOOD-BRAIN BARRIER TRANSPORTERS AND RECEPTORS BY NEXT GENERATION RNA SEQUENCING
Q. Liu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
WHIM Syndrome Caused by Waldenstrom's Macroglobulinemia-Associated Mutation CXCR4
Qian Liu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2016)
CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia
Diana Passaro et al.
CANCER CELL (2015)
Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment
Stefania Scala
CLINICAL CANCER RESEARCH (2015)
Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?
Zhao-Hua Shen et al.
MEDICAL ONCOLOGY (2015)
Concise Review: CXCR4/CXCL12 Signaling in Immature Hematopoiesis-Lessons From Pharmacological and Genetic Models
Darja Karpova et al.
STEM CELLS (2015)
The structure of a CXCR4:chemokine complex
Tracy Marie Handel
FRONTIERS IN IMMUNOLOGY (2015)
Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives
Lukas Pawig et al.
FRONTIERS IN IMMUNOLOGY (2015)
Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors
Concepcion Gomez-Mouton et al.
BLOOD (2015)
CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P-directed survival signalling in Waldenstrom macroglobulinaemia cells
Yang Cao et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia
Y. Cao et al.
LEUKEMIA (2015)
The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
Zachary R. Hunter et al.
BLOOD (2014)
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel et al.
BLOOD (2014)
Hierarchical Organization of Multi-Site Phosphorylation at the CXCR4 C Terminus
Wiebke Mueller et al.
PLOS ONE (2013)
Filamins in Mechanosensing and Signaling
Ziba Razinia et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 41 (2012)
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4
Qian Liu et al.
BLOOD (2012)
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1
Lucy S. Hodge et al.
BLOOD (2011)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome
David H. McDermott et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 Signaling
John M. Busillo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
F-actin-binding protein drebrin regulates CXCR4 recruitment to the immune synapse
Manuel Perez-Martinez et al.
JOURNAL OF CELL SCIENCE (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Angelique Levoye et al.
BLOOD (2009)
Imaging chemokine receptor dimerization with firefly luciferase complementation
Kathryn E. Luker et al.
FASEB JOURNAL (2009)
A functional heteromeric MIF receptor formed by CD74 and CXCR4
Verena Schwartz et al.
FEBS LETTERS (2009)
The E3 Ubiquitin Ligase Atrophin Interacting Protein 4 Binds Directly To The Chemokine Receptor CXCR4 Via a Novel WW Domain-mediated Interaction
Deepali Bhandari et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Impaired Recruitment of Grk6 and β-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor
Peter J. McCormick et al.
PLOS ONE (2009)
CXCR4 dimerization and β-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Bernard Lagane et al.
BLOOD (2008)
Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling
Karl Balabanian et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Heterotrimeric G protein activation by G-protein-coupled receptors
William M. Oldham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7
Frederic Sierro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Establishment of BCWM.1 cell line for Waldenstrom's macroglobulinemia with productive in vivo engraftment in SCID-hu mice
Daniel Ditzel Santos et al.
EXPERIMENTAL HEMATOLOGY (2007)
Regulation of CXCR4 signaling
John M. Busillo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133(+) cells
Sinead Forde et al.
BLOOD (2007)
Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome
T Kawai et al.
EXPERIMENTAL HEMATOLOGY (2005)
WHIM4 syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
K Balabanian et al.
BLOOD (2005)
Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome
AV Gulino et al.
BLOOD (2004)
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
PA Hernandez et al.
NATURE GENETICS (2003)
Cutting edge:: Association of the motor protein nonmuscle myosin heavy chain-IIA with the C terminus of the chemokine receptor CXCR4 in T lymphocytes
M Rey et al.
JOURNAL OF IMMUNOLOGY (2002)
Epstein-Barr virus-associated T lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome
S Imashuku et al.
ANNALS OF HEMATOLOGY (2002)
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
M Mellado et al.
EMBO JOURNAL (2001)
B-cell lymphoma in a patient with WHIM syndrome
KM Chae et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
β-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between β-arrestin and CXCR4
ZJ Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
